Sarepta Therapeutics
SRPT
SRPT
389 hedge funds and large institutions have $9.51B invested in Sarepta Therapeutics in 2019 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
14% more funds holding
Funds holding: 340 → 389 (+49)
6% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 110
0.42% less ownership
Funds ownership: 99.26% → 98.84% (-0.42%)
Holders
389
Holding in Top 10
10
Calls
$573M
Puts
$391M
Top Buyers
| 1 | +$311M | |
| 2 | +$122M | |
| 3 | +$112M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$108M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
+$78.1M |
Top Sellers
| 1 | -$238M | |
| 2 | -$90.7M | |
| 3 | -$82.3M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$60.2M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$60M |